Revolution Medicines (RVMD) Accumulated Depreciation (2019 - 2026)
Revolution Medicines (RVMD) posted quarterly Accumulated Depreciation of $30.7 million for Q1 2026, up 31.22% year-over-year from $23.4 million in Q1 2025, and up 7.6% quarter-over-quarter from $28.5 million in Q4 2025.
Revolution Medicines (RVMD) Accumulated Depreciation (2019 - 2026) Analysis & Trends
Revolution Medicines' Accumulated Depreciation history runs 8 years deep, the most recent figure standing at $30.7 million for Q1 2026.
- In Q1 2026, Accumulated Depreciation rose 31.22% year-over-year to $30.7 million; the TTM figure through Mar 2026 stood at $30.7 million (up 31.22% YoY), while the FY2025 annual figure was $28.5 million, up 30.66% from the prior year.
- Accumulated Depreciation for Q1 2026 stood at $30.7 million, up from $28.5 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $30.7 million in Q1 2026, with the low at $11.6 million in Q1 2022.
- The 5-year median for Accumulated Depreciation is $18.9 million (2024), against an average of $19.9 million.
- The sharpest annual moves came in 2023 and 2024: Accumulated Depreciation soared 35.59% in 2023, then rose 19.86% in 2024.
- Revolution Medicines' Accumulated Depreciation stood at $14.5 million in 2022, then rose by 22.12% to $17.7 million in 2023, then gained by 23.34% to $21.8 million in 2024, then surged by 30.66% to $28.5 million in 2025, then gained by 7.6% to $30.7 million in 2026.
- Business Quant data shows RVMD's Accumulated Depreciation at $30.7 million in Q1 2026, $28.5 million in Q4 2025, and $27.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.84 Mn |
| Mar 31, 2026 | 30.68 Mn |
| Dec 31, 2025 | 28.51 Mn |
| Sep 30, 2025 | 27.01 Mn |
| Jun 30, 2025 | 25.03 Mn |
| Mar 31, 2025 | 23.38 Mn |
| Dec 31, 2024 | 21.82 Mn |
| Sep 30, 2024 | 21.67 Mn |
| Jun 30, 2024 | 20.45 Mn |
| Mar 31, 2024 | 18.88 Mn |
| Dec 31, 2023 | 17.69 Mn |
| Sep 30, 2023 | 18.08 Mn |
| Jun 30, 2023 | 16.83 Mn |
| Mar 31, 2023 | 15.67 Mn |
| Dec 31, 2022 | 14.49 Mn |
| Sep 30, 2022 | 13.48 Mn |
| Jun 30, 2022 | 12.49 Mn |
| Mar 31, 2022 | 11.56 Mn |
| Dec 31, 2021 | 10.81 Mn |
| Sep 30, 2021 | 10.18 Mn |